River Vision Development Corp.'s Acquisition

River Vision Development Corp. was acquired by Horizon Pharma on May 08, 2017.

River Vision Development Corp. specializes in the development of teprotumumab, a therapy for an eye condition called Graves' ophthalmopathy.…

Articles about River Vision Development Corp.'s Acquisition: